Brian G. Schuster - Concepedia

Author

Brian G. Schuster

Also Known As

B G Schuster, B SCHUSTER, B Schuster, B. G. Schuster, B.G. Schuster, Brian G Schuster, Brian G. Schuster, Brian Schuster, Brian G. Schuster

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Walter Reed Army Institute of Research Armed Forces Research Institute of Medical Science University of Ibadan

About

Brian G. Schuster is an author at Walter Reed Army Institute of Research specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.4K
2	Engineering	2	2	97
3	Health Sciences	1	1	50
4	Public Health	1	1	14
5	Social Sciences	1	1	14

Brian G. Schuster

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Fatal Neurotoxicity of Arteether and Artemether Thomas G. Brewer, Stephen J. Grate, James O. Peggins, American Journal of Tropical Medicine and Hygiene Progressive SyndromeFatal NeurotoxicityMedicineHerbal MedicineHerb-drug Interaction	1994	269
Neurotoxicity in animals due to arteether and artemether Thomas G. Brewer, James O. Peggins, Stephen J. Grate, Transactions of the Royal Society of Tropical Medicine and Hygiene	1994	251
TEXTBOOK OF PHARMACOLOGY Brian G. Schuster Military Medicine Molecular PharmacologyPharmacological StudyPharmacodynamicsLocal PharmacologyBehavioral Pharmacology	1992	142
Medicinal plants in the fight against leishmaniasis Maurice M. Iwu, Joan E. Jackson, Brian G. Schuster Parasitology Today Antiparasitic AgentMedicineParasitic ProtozoaMedicinal PlantsPharmacology	1994	134
First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial. Ralf P. Brueckner, Kenneth C. Lasseter, E T Lin, American Journal of Tropical Medicine and Hygiene Antiparasitic AgentMalariaPharmacologyHerb-drug InteractionWr 238605	1998	131
Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi. Reynaldo Dietze, Sandra Carvalho, Luiz Carlos Pedrosa Valli, American Journal of Tropical Medicine and Hygiene Unusual Clinical FeaturesAfrican TrypanosomiasisAntiparasitic AgentParasitic ProtozoaLeishmania Chagasi	2001	126
Production of Antibodies Against Phosphocholine, Phosphatidylcholine, Sphingomyelin, and Lipid A by Injection of Liposomes Containing Lipid A Brian G. Schuster, Martin Neidig, Barbara M. Alving, The Journal of Immunology Proteinlipid InteractionMicrobial PathogensImmunologyImmune RegulationInnate Immunity	1979	99
Tolerability of prophylactic Lariam regimens. Ellen F. Boudreau, Brian G. Schuster, Juan Francisco Sánchez, PubMed Evidence-based MedicineSleep DisturbancePharmacotherapyMg SaltLogistic Analysis	1993	93
Randomized Dose‐Ranging Study of the Safety and Efficacy of WR 238605 (Tafenoquine) in the Prevention of Relapse of<i>Plasmodium vivax</i>Malaria in Thailand Douglas S. Walsh, S Looareesuwan, Polrat Wilairatana, The Journal of Infectious Diseases Dose‐ranging StudyClinical TherapeuticAntiparasitic AgentMedicineMalaria	1999	91
Phase 2 Efficacy Trial of an Oral 8-Aminoquinoline (WR6026) for Treatment of Visceral Leishmaniasis James A. Sherwood, G. Gachihi, R. Muigai, Clinical Infectious Diseases	1994	91

Page 1